Stock BDTX BLACK DIAMOND THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Black Diamond Therapeutics, Inc.

Equities

BDTX

US09203E1055

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-21 EDT 		5-day change 1st Jan Change
4.97 USD +1.43% Intraday chart for Black Diamond Therapeutics, Inc. -13.41% +76.87%
05-16 HC Wainwright Adjusts Price Target on Black Diamond Therapeutics to $11 From $12, Keeps Buy Rating MT
05-09 Black Diamond Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
BLACK DIAMOND THERAPEUTICS, INC. Stock Black Diamond Therapeutics, Inc.
 257M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 107B
BIONTECH SE Stock BioNTech SE
 22.31B -
ARGENX SE Stock argenx SE
 21.6B -
BEIGENE, LTD. Stock BeiGene, Ltd.
 18.23B -
  1. Stock Market
  2. Equities
  3. BDTX Stock
  4. Charts Black Diamond Therapeutics, Inc.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW